Author photo

By Steve Erdman
Nebraska 47th District 

Therapeutics for COVID-19


January 5, 2022

In my July 10, 2020 article I wrote about the use of certain therapeutic re-purposed prescription drugs for the treatment of COVID-19 symptoms. I especially talked about the potential benefits of inhaled budesonide and hydroxychloroquine. After I published that article, I received some harsh criticism from several folks who accused me of not following the science. Well, it turns out 18 months later that I was right all along.

Treating the symptoms of original COVID-19, along with its delta and omicron variants, has been driven by politics rather than science from the very beginning. The...

For access to this article please sign in or subscribe.


Reader Comments(0)


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2023